Genetic network identification by high density, multiplexed reversed transcriptional (HD-MRT) analysis in steroidogenic axis model cell lines

Molecular Genetics and Metabolism

Volumn 77, Issue 1-2, 2002, Pages 159-178

  Clipsham, R ^a   Zhang, Y H ^b   Huang, B L ^b   McCabe, E R B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; PRIMER DNA; RNA; STEROID;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DEVELOPMENT; DISEASE SEVERITY; EMBRYO; FEMALE; FETUS; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC MODEL; GENETIC TRANSCRIPTION; HIGH DENSITY MULTIPLEXED REVERSED TRANSCRIPTION POLYMERASE CHAIN REACTION; HUMAN; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE;

ANIMALIA;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; MICE; MODELS, GENETIC; MUTATION; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEROIDS; TRANSCRIPTION, GENETIC;

EID: 0036395157     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(02)00119-1     Document Type: Article

References (173)

1. D.N. Orth, W.J. Kovacs, C.R. DeBold, The adrenal cortex, in: J.D. Wilson, D.W. Foster (Eds.), Williams Textbook of Endocrinology, Saunders, Philadelphia, 1992, pp. 489-619.
2. E.R.B. McCabe, Adrenal hypoplasias and aplasias, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K.W. Kinzler, B. Vogelstein (Eds.), The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, 2001, pp. 4263-4274.
3. K. Morohashi, The ontogenesis of the steroidogenic tissues, Genes Cells 2 (1997) 95-106.
4. R.C. Clipsham, Y.-H. Zhang, B.-L. Huang, E.R.B. McCabe, Ahch expression in murine embryonic stem cells supports role early in development prior to differentiation of steroidogenic axis, Am. J. Hum. Genet. A 67 (2000) 170.
5. A. Swain, V. Narvaez, P. Burgoyne, G. Camerino, R. Lovell-Badge, Dax1 antagonizes Sry action in mammalian sex determination, Nature 391 (1998) 761-767.
6. R.N. Yu, M. Ito, T.L. Saunders, S.A. Camper, J.L. Jameson, Role of Ahch in gonadal development and gametogenesis, Nat. Genet. 20 (1998) 353-357.
7. B. Jeffs, M. Ito, R.N. Yu, F.A. Martinson, Z.J. Wang, L.T. Doglio, J.L. Jameson, Sertoli cell-specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice, Endocrinology 142 (2001) 2481-2488.
8. S.B. Lee, D.A. Haber, Wilms rumor and the WT1 gene, Exp. Cell Res. 264 (2001) 74-99.
9. Y.-H. Zhang, W. Guo, R.L. Wagner, B.-L. Huang, L. McCabe, E. Vilain, T.P. Burris, K. Anyane-Yeboa, A.H.M. Burghes, D. Chitayat, A.E. Chudley, M. Genel, J.M. Gertner, G.J. Klingensmith, S.N. Levine, J. Nakamoto, M.I. New, R.A. Pagon, J.G. Pappas, C.A. Quigley, I.M. Rosenthal, J.D. Baxter, R.J. Fletterick, E.R.B. McCabe, DAX1 mutations map to putative structural domains in a deduced three-dimensional model, Am. J. Hum. Genet. 62 (1998) 855-864.
10. T. Wagner, J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F.D. Bricarelli, J. Keutel, E. Hustert, U. Wolf, N. Tommerup, W. Schempp, G. Scherer, Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9, Cell 79 (1994) 1111-1120.
11. C.E. Bishop, D.J. Whitworth, Y. Qin, A.I. Agoulnik, I.U. Agoulnik, W.R. Harrison, R.R. Behringer, P.A. Overbeek, A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse, Nat. Genet. 26 (2000) 490-494.
12. T. Tajima, K. Fujieda, N. Kouda, J. Nakae, W.L. Miller, Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency, J. Clin. Endocrinol. Metab. 86 (2001) 3820-3825.
13. J.C. Achermann, M. Ito, M. Ito, P.C. Hindmarsh, J.L. Jameson, A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans, Nat. Genet. 22 (1999) 125-126.
14. U. Dressel, D. Thormeyer, B. Altincicek, A. Paululat, M. Eggert, S. Schneider, S.P. Tenbaum, R. Renkawitz, A. Baniahmad, Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily, Mol. Cell. Biol. 19 (1999) 3383-3394.
15. W. Seol, H.-S. Choi, D.D. Moore, An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors, Science 272 (1996) 1336-1339.
16. L.H. Wang, S.Y. Tsai, R.G. Cook, W.G. Beattie, M.J. Tsai, B.W. O'Malley, COUP transcription factor is a member of the steroid receptor superfamily, Nature 340 (1989) 163-166.
17. K.B. Horwitz, T.A. Jackson, D.L. Bain, J.K. Richer, G.S. Takimoto, L. Tung, Nuclear receptor coactivators and corepressors, Mol. Endocrinol. 10 (1996) 1167-1177.
18. X. Luo, Y. Ikeda, K.L. Parker, A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation, Cell 77 (1994) 481-490.
19. M. Ito, R. Yu, J.L. Jameson, DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita, Mol. Cell. Biol. 17 (1997) 1476-1483.
20. P.A. Crawford, C. Dorn, Y. Sadovsky, J. Milbrandt, Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1, Mol. Cell. Biol. 18 (1998) 2949-2956.
21. M.W. Nachtigal, Y. Hirokawa, D.L. Enyeart-VanHouten, J.N. Flanagan, G.D. Hammer, H.A. Ingraham, Wilms' Tumor1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression, Cell 93 (1998) 445-454.
22. J. Kim, D. Pawritt, N. Bardeesy, E. Torban, C. Vicaner, P. Goodyer, B. Zabel, J. Pelletier, The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation, Mol. Cell. Biol. 19 (1999) 2289-2299.
23. R.N. Yu, M. Ito, J.L. Jameson, The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element, Mol. Endocrinol. 12 (1998) 1010-1022.
24. T. Sugawara, S. Abe, N. Sakuragi, Y. Fujimoto, E. Nomura, K. Fujieda, M. Saito, S. Fujimoto, RIP 140 modulates transcription of the steroidogenic acute regulatory protein gene through interactions with both SF-1 and DAX-1, Endocrinology 142 (2001) 3570-3577.
25. T.W. Sandhoff, M.P. McLean, Repression of the rat steroidogenic acute regulatory (StAR) protein gene by PGF2α is modulated by the negative transcription factor DAX-1, Endocrine 10 (1999) 83-91.
26. E. Vilain, W. Guo, Y.-H. Zhang, E.R.B. McCabe, DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line, Biochem. Mol. Med. 61 (1997) 1-8.
27. Y. Ninomiya, M. Okada, N. Kotomura, K. Suzuki, T. Tsukiyama, O. Niwa, Genomic organization and isoforms of the mouse ELP gene, J. Biochem. 118 (1995) 380-389.
28. T.A. Jackson, J.K. Richer, D.L. Bain, G.S. Takimoto, L. Tung, K.B. Horwitz, The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the co-repressors N-CoR or SMRT, Mol. Endocrinol. 11 (1997) 693-705.
29. A. Swain, E. Zanaria, A. Hacker, R. Lovell-Badge, G. Camerino, Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function, Nat. Genet. 12 (1996) 404-409.
30. L. Schaefer, M.L. Beermann, J.B. Miller, Coding sequence, genomic organization, chromosomal localization, and expression pattern of the signalosome component Cops2: the mouse homologue of Drosophila Alien, Genomics 56 (1999) 310-316.
31. W. Seol, M. Chung, D.D. Moore, Novel receptor interaction and repression domains in the orphan receptor SHP, Mol. Cell. Biol. 17 (1997) 7126-7131.
32. K.M. Caron, S.C. Soo, K.L. Parker, Targeted disruption of StAR provides novel insights into congenital adrenal hyperplasia, Endocr. Res. 24 (1998) 827-834.
33. P.P. Dwivedi, G.E.O. Muscat, P.J. Bailey, J.L. Omdahl, B.K. May, Repression of basal transcription by vitamin D receptor: evidence for iteraction of unliganded vitamin D receptor with two receptor interaction domains in RIP13Δ1, J. Mol. Endocrinol. 20 (1998) 327-335.
34. M.L. Privalsky, Regulation of SMRT and N-CoR corepressor function, Curr. Top. Microbiol. Immunol. 254 (2001) 117-136.
35. W. Seol, M.J. Mahon, Y.K. Lee, D.D. Moore, Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR, Mol. Endocrinol. 10 (1996) 1646-1655.
36. R.N. Cohen, A. Putney, F.E. Wondisford, A.N. Hollenberg, The nuclear corepressors recognize distinct nuclear receptor complexes, Mol. Endocrinol. 14 (2000) 900-914.
37. I. Zamir, H.P. Harding, G.B. Atkins, A. Horlein, C.K. Glass, M.G. Rosenfeld, M.A. Lazar, A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains, Mol. Cell. Biol. 16 (1996) 5458-5465.
38. S. Sande, M.L. Privalsky, Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors, Mol. Endocrinol. 10 (1996) 813-825.
39. M. Downes, L.J. Burke, P.J. Bailey, G.E. Muscat, Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA α and RVR: physical association is dependent on the E region of the orphan receptors, Nucleic Acids Res. 24 (1996) 4379-4386.
40. P. Ordentlich, M. Downes, R.M. Evans, Corepressors and nuclear hormone receptor function, Curr. Top. Microbiol. Immunol. 254 (2001) 101-116.
41. Y. Ikeda, A. Swain, T.J. Weber, K.E. Hentges, E. Zanaria, E. Lalli, K.T. Tamai, P. Sassone-Corsi, R. Lovell-Badge, G. Camerino, K.L. Parker, Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development, Mol. Endocrinol. 10 (1996) 1261-1272.
42. E. Vilain, E.R.B. McCabe, DAX1 and related orphan receptors, in: T.P. Burris, E.R.B. McCabe (Eds.), Nuclear Receptors and Genetic Disease, Academic Press, London, 2001, pp. 179-196.
43. J.C. Achermann, J.D. Baxter, J.L. Jameson, SF-1 and DAX-1 in adrenal development and pathology. Clinical and molecular aspects, in: I.A. Hughes, A.J.L. Clark (Eds.), Adrenal Disease in Childhood, Karger, New York, 2000, pp. 1-23.
44. J.T. Yarrington, Adrenal cortex, in: U. Mohr, D.L. Dungworth, C.C. Capen (Eds.), Pathobiology of the Aging Mouse, ILSI Press, Washington, DC, 1996, pp. 125-133.
45. J.T. Yarrington, J.O. Johnston, Aging in the adrenal cortex, in: U. Mohr, D.L. Dungworth, C.C. Capen (Eds.), Pathobiology of the Aging Rat, ILSI Press, Washington, DC, 1992, pp. 227-244.
46. T.B. Dunn, Normal and pathologic anatomy of the adrenal gland of the mouse, including neoplasms, J. Natl. Cancer Inst. 44 (1970) 1323-1389.
47. R. Schneider, H.C. Card, Instabilities and oscillation in the deterministic Boltzmann machine, Int. J. Neural. Syst. 10 (2000) 321-330.
48. Z. Burstein, A network model of developmental gene hierarchy, J. Theoret. Biol. 174 (1995) 1-11.
49. F. Azuaje, A computational neural approach to support the discovery of gene function and classes of cancer, IEEE Trans. Biomed. Eng. 48 (2001) 332-339.
50. L.F. Wessels, E.P. van Someren, M.J. Reinders, A comparison of genetic network models, Pac. Symp. Biocomput. Annu. Symp. (2001) 508-519.
51. N. Barkai, S. Leibler, Robustness in simple biochemical networks, Nature 387 (1997) 913-917.
52. L. Hartwell, A robust view of biochemical pathways, Nature 387 (1997) 855-857.
53. Y. Tu, How robust is the Internet? Nature 406 (2000) 353-354.
54. H. Jeong, B. Tombor, R. Albert, Z.N. Ottval, A.-L. Barabási, The large-scale organization of metabolic networks, Nature 407 (2000) 651-654.
55. R. Albert, H. Jeong, A.-L. Barabási, Error and attack tolerance of complex networks, Nature 406 (2000) 378-381.
56. K.M. Dipple, J.K. Phelan, E.R. McCabe, Consequences of complexity within biological networks: robustness and health, or vulnerability and disease, Mol. Genet. Metab. 74 (2001) 45-50.
57. K.M. Dipple, E.R.B. McCabe, Modifier genes convert "simple" Mendelian disorders to complex traits, Mol. Genet. Metab. 71 (2000) 43-50.
58. K.M. Dipple, E.R.B. McCabe, Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics, Am. J. Hum. Genet. 66 (2000) 1729-1735.
59. E.R. McCabe, Vulnerability within a robust complex system: DAX-1 mutations and steroidogenic axis development, J. Clin. Endocrinol. Metab. 87 (2002) 41-43.
60. K.L. Parker, B.P. Schimmer, Genetics of the development and function of the adrenal cortex, Rev. Endocr. Metab. Disord. 2 (2001) 245-252.
61. M.L. Bland, C.A. Jamieson, S.F. Akana, S.R. Bornstein, G. Eisenhofer, M.F. Dallman, H.A. Ingraham, Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response, Proc. Natl. Acad. Sci. USA 97 (2000) 14488-14493.
62. B. Bardoni, E. Zanaria, S. Guioli, G. Floridia, K.C. Worley, G. Tonini, E. Ferrante, G. Chiumello, E.R.B. McCabe, M. Fraccaro, O. Zuffardi, G. Camerino, A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal, Nat. Genet. 7 (1994) 497-501.
63. K. Morohashi, H. Iida, M. Nomura, O. Hatano, S. Honda, T. Tsukiyama, O. Niwa, T. Hara, A. Takakusu, Y. Shibata, Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues, Mol. Endocrinol. 8 (1994) 643-653.
64. J.J. Tremblay, R.S. Viger, Nuclear receptor Dax-1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells, Biol. Reprod. 64 (2001) 1191-1199.
65. R. Shimamura, G.C. Fraizer, J. Trapman, Y. Lau, G.F. Saunders, The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor, Clin. Cancer Res. 3 (1997) 2571-2580.
66. A. Hammes, J.K. Guo, G. Lutsch, J.R. Leheste, D. Landrock, U. Ziegler, M.C. Gubler, A. Schedl, Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation, Cell 106 (2001) 319-329.
67. M. Patel, K.S. Dorman, Y.H. Zhang, B.L. Huang, A.P. Arnold, J.S. Sinsheimer, E. Vilain, E.R.B. McCabe, Primate DAX1, SRY, and SOX9: evolutionary stratification of sex determination pathway, Am. J. Hum. Genet. 68 (2001) 275-280.
68. V.P. Vidal, M.C. Chaboissier, D.G. de Rooij, A. Schedl, Sox9 induces testis development in XX transgenic mice, Nat. Genet. 28 (2001) 216-217.
69. P. Chomczynski, N. Sacchi, Single step method of RNA isolation by acid guandinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
70. K. Zimmermann, J.W. Mannhalter, Technical aspects of quantitative competitive PCR, Biotechniques 21 (1996) 268-279.
71. 280 and on accuracy of mRNA quantitation by reverse transcriptase-PCR, PCR Methods Appl. 1 (1992) 286-290.
72. G. Lennon, C. Auffray, M. Polymeropoulos, M.B. Soares, The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression, Genomics 33 (1996) 151-152.
73. G.M. Church, W. Gilbert, Genomic sequencing, Proc. Natl. Acad. Sci. USA 81 (1984) 1991-1995.
74. N.A. Hanley, D.M. Hagan, M. Clement-Jones, S.G. Ball, T. Strachan, L. Salas-Cortés, K. McElreavey, S. Lindsay, S. Robson, P. Bullen, H. Ostrer, D.I. Wilson, SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development, Mech. Dev. 91 (2000) 403-407.
75. T.P. Burris, W. Guo, T. Le, E.R.B. McCabe, Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter, Biochem. Biophys. Res. Commun. 214 (1995) 576-581.
76. P.J. Bailey, D.H. Dowhan, K. Franke, L.J. Burke, M. Downes, G.E.O. Muscat, Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13Δ1, J. Steroid Biochem. Mol. Biol. 63 (1997) 165-174.
77. A. Caricasole, A. Duarte, S.H. Larsson, N.D. Hastie, M. Little, G. Holmes, I. Todorov, A. Ward, RNA binding by the Wilms tumor suppressor zinc finger proteins, Proc. Natl. Acad. Sci. USA 93 (1996) 7562-7566.
78. B. Altincicek, S.P. Tenbaum, U. Dressel, D. Thormeyer, R. Renkawitz, A. Baniahmad, Interaction of the corepressor alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita, J. Biol. Chem. 275 (2000) 7662-7667.
79. A.J. Reinhart, S.C. Williams, B.J. Clark, D.M. Stocco, SF-1 (steroidogenic factor-1) and C/EBPβ (CCAAT/enhancer binding protein-β) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter, Mol. Endocrinol. 10 (1999) 83-91.
80. Y.-K. Lee, K.L. Parker, H.-S. Choi, D.D. Moore, Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers, J. Biol. Chem. 274 (1999) 20869-20873.
81. R.C. Clipsham, E.R. McCabe, Single tube gene-specific expression analysis by high primer density multiplex reverse transcription, Mol. Genet. Metab. 74 (2001) 435-448.
82. E. Zanaria, F. Muscatelli, B. Bardoni, T.M. Strom, S. Guioli, W. Guo, E. Lalli, C. Moser, A.P. Walker, E.R.B. McCabe, T. Meitinger, A.P. Monaco, P. Sassone-Corsi, G. Camerino, An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita, Nature 372 (1994) 635-641.
83. D.S. Bae, M.L. Schaefer, B.W. Partan, L. Muglia, Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue, Endocrinology 137 (1996) 3921-3927.
84. R. Kimura, H. Yoshii, M. Nomura, N. Kotomura, T. Mukai, S. Ishihara, K. Ohba, T. Yanase, O. Gotoh, H. Nawata, K. Morohashi, Identification of novel first exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specific usage, Biochem. Biophys. Res. Commun. 278 (2000) 63-71.
85. M.S. Ramayya, J. Zhou, T. Kino, J.H. Segars, C.A. Bondy, G.P. Chrousos, Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies, J. Clin. Endocrinol. Metab. 82 (1997) 1799-1806.
86. D.S. Lala, D.A. Rice, K.L. Parker, Steroidogenic factor 1, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor 1, Mol. Endocrinol. 6 (1992) 1249-1258.
87. E. Wright, M.R. Hargrave, J. Christiansen, L. Cooper, J. Kun, T. Evans, U. Gangadharan, A. Greenfield, P. Koopman, The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos, Nat. Genet. 9 (1995) 15-20.
88. J. Pelletier, M. Schalling, A.J. Buckler, A. Rogers, D.A. Haber, D. Housman, Expression of the Wilms' tumor gene WT1 in the murine urogenital system, Genes Dev. 5 (1991) 1345-1356.
89. A.J. Buckler, J. Pelletier, D.A. Haber, T. Glaser, D.E. Housman, Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development, Mol. Cell. Biol. 11 (1991) 1707-1712.
90. H.K. Lee, R.S. Ahn, H.B. Kwon, J. Soh, Nucleotide sequence of rat steroidogenic acute regulatory protein complementary DNA, Biochem. Biophys. Res. Commun. 230 (1997) 528-532.
91. H.-K. Lee, Y.-K. Lee, S.-H. Park, Y.-S. Kim, S.H. Park, J.W. Lee, H.-B. Kwon, J. Soh, D.D. Moore, H.-S. Choi, Structure and expression of the orphan nuclear receptor SHP gene, J. Biol. Chem. 273 (1998) 14398-14402.
92. N. Masuda, H. Yasumo, T. Tamura, N. Hashiguchi, T. Furusawa, T. Tsukamoto, H. Sadano, T. Osumi, An orphan nuclear receptor acking a zinc-finger DNA-binding domain: interaction with several nuclear receptors, Biochim. Biophys. Acta 1350 (1997) 27-32.
93. B. Dumas, H.P. Harding, H.S. Choi, K.A. Lehmann, M. Chung, M.A. Lazar, D.D. Moore, A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb, Mol. Endocrinol. 8 (1994) 996-1005.
94. C.H. Lee, C. Chinpaisal, L.N. Wei, Cloning and characterization of mouse RIP 140, a corepressor for nuclear orphan receptor TR2, Mol. Cell. Biol. 18 (1998) 6745-6755.
95. A.J. Horlein, A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C.K. Glass, Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature 377 (1995) 397-404.
96. P. Ordentlich, M. Downes, W. Xie, A. Genin, N.B. Spinner, R.M. Evans, Unique forms of human and mouse nuclear receptor corepressor SMRT, Proc. Natl. Acad. Sci. USA 96 (1999) 2639-2644.
97. J.P. Mather, Establishment and characterization of two distinct mouse testicular epithelial cell lines, Biol. Reprod. 23 (1980) 243-252.
98. J.P. Mather, L.Z. Zhuang, V. Perez-Infante, D.M. Phillips, Culture of testicular cells in hormone-supplemented serum-free medium, Ann. N. Y. Acad. Sci. 383 (1982) 44-68.
99. Y. Yasumura, A. Tashjian, G. Sato, Establishment of four functional, clonal strains of animal cells in culture, Science 254 (1996) 1186-1189.
100. A.I. Cohen, J. Furth, R.F. Buffett, Histological and physiological characteristics of Hormone-Secreting transplantable Adrenal tumors in Mice and Rats, Am. J. Pathol. 33 (1957) 631-644.
101. W.E. Rainey, I.M. Bird, J.I. Mason, The NCI-H295 cell line: a pluripotent model for human adrenocortical studies, Mol. Cell. Endocrinol. 100 (1994) 45-50.
102. B. Staels, D.W. Hum, W.L. Miller, Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal, Mol. Endocrinol. 7 (1993) 423-433.
103. H. Shibata, Z. Nawaz, S.Y. Tsai, B.W. O'Malley, M.-J. Tsai, Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor, and thyroid hormone receptor (SMRT), Mol. Endocrinol. 11 (1997) 714-724.
104. M. Soderstrom, A. Vo, T. Heinzel, R.M. Lavinsky, W.M. Yang, E. Seto, D.A. Peterson, M.G. Rosenfeld, C.K. Glass, Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes, Mol. Endocrinol. 11 (1997) 682-692.
105. R.M. Lavinsky, K. Jepsen, T. Heinzel, J. Torchia, T.-M. Mullen, R. Schiff, A.L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch, S.G. Hilsenbeck, C.K. Osborne, C.K. Glass, M.G. Rosenfeld, D.W. Rose, Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes, Proc. Natl. Acad. Sci. USA 95 (1998) 2920-2925.
106. T. Ikonen, J.J. Palvimo, O.A. Janne, Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators, J. Biol. Chem. 272 (1997) 29821-29828.
107. A. Baniahmad, U. Dressel, R. Renkawitz, Cell-specific inhibition of retinoic acid receptor-α silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR, Mol. Endocrinol. 12 (1998) 504-512.
108. J.D. Chen, K. Umesono, R.M. Evans, SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers, Proc. Natl. Acad. Sci. USA 93 (1996) 7567-7571.
109. M.R. Ladomery, J. Slight, G.S. Mc, N.D. Hastie, Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein, J. Biol. Chem. 274 (1999) 36520-36526.
110. I. Zamir, J. Zhang, M.A. Lazar, Stoichiometric and steric principles governing repression by nuclear hormone receptors, Genes Dev. 11 (1997) 835-846.
111. M.G. Guenther, O. Barak, M.A. Lazar, The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3, Mol. Cell. Biol. 21 (2001) 6091-6101.
112. R. Kurokawa, M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M.G. Rosenfeld, C.K. Glass, Polarity-specific activities of retinoic acid receptors determined by a co-repressor, Nature 377 (1995) 451-454.
113. S.M. Yoh, M.L. Privalsky, Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor, J. Biol. Chem. 276 (2001) 16857-16867.
114. P.R. Manna, P. Roy, B.J. Clark, D.M. Stocco, I.T. Huhtaniemi, Interaction of thyroid hormone and steroidogenic acute regulatory (StAR) protein in the regulation of murine Leydig cell steroidogenesis, J. Steroid Biochem. Mol. Biol. 76 (2001) 167-177.
115. A. Schedl, N. Hastie, Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development, Mol. Cell. Endocrinol. 140 (1998) 65-69.
116. J.H. Laity, H.J. Dyson, P.E. Wright, Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein, Proc. Natl. Acad. Sci. USA 97 (2000) 11932-11935.
117. S.M. Hewitt, G.C. Fraizer, Y.J. Wu, F.J. Rauscher III, G.F. Saunders, Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation, J. Biol. Chem. 271 (1996) 8588-8592.
118. J.H. Laity, J. Chung, H.J. Dyson, P.E. Wright, Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes, Biochemistry 39 (2000) 5341-5348.
119. A.L. Gashler, D.T. Bonthron, S.L. Madden, F.J. Rauscher III, T. Collins, V.P. Sukhatme, Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1, Proc. Natl. Acad. Sci. USA 89 (1992) 10984-10988.
120. Z.Y. Wang, Q.Q. Qiu, T.F. Deuel, The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains, J. Biol. Chem. 268 (1993) 9172-9175.
121. Z.Y. Wang, Q.Q. Qiu, J. Huang, M. Gurrieri, T.F. Deuel, Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways, Oncogene 10 (1995) 415-422.
122. K. Moorwood, A. Salpekar, S.M. Ivins, J. Hall, R.M. Powlesland, K.W. Brown, K. Malik, Transactivation of the Wt1 antisense promoter is unique to the WT1[+/)] isoform, FEBS Lett. 456 (1999) 131-136.
123. C. Englert, M. Vidal, S. Maheswaran, Y. Ge, R.M. Ezzell, K.J. Isselbacher, D.A. Haber, Truncated WT1 mutants alter the subnuclear localization of the wild-type protein, Proc. Natl. Acad. Sci. USA 92 (1995) 11960-11964.
124. S.H. Larsson, J.P. Charlieu, K. Miyagawa, D. Engelkamp, M. Rassoulzadegan, A. Ross, F. Cuzin, H.V. van, N.D. Hastie, Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing, Cell 81 (1995) 391-401.
125. R.C. Davies, C. Calvio, E. Bratt, S.H. Larsson, A.I. Lamond, N.D. Hastie, WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes, Genes Dev. 12 (1998) 3217-3225.
126. D.A. Haber, R.L. Sohn, A.J. Buckler, J. Pelletier, K.M. Call, D.E. Housman, Alternative splicing and genomic structure of the Wilms tumor gene WT1, Proc. Natl. Acad. Sci. USA 88 (1991) 9618-9622.
127. S. Barbaux, P. Niaudet, M.C. Gubler, J.P. Grunfeld, F. Jaubert, F. Kuttenn, C.N. Fekete, N. Souleyreau-Therville, E. Thibaud, M. Fellous, K. McElreavey, Donor splice-site mutations in WT1 are responsible for Frasier syndrome, Nat. Genet. 17 (1997) 467-470.
128. B. Klamt, A. Koziell, F. Poulat, P. Wieacker, P. Scambler, P. Berta, M. Gessler, Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1+/-KTS splice isoforms, Hum. Mol. Genet. 7 (1998) 709-714.
129. II70, Nucleic Acids Res. 26 (1998) 2899-2907.
130. X. Wen, S. Fuhrman, G.S. Michaels, D.B. Carr, S. Smith, J.L. Barker, R. Somogyi, Large-scale temporal gene expression mapping of central nervous system development, Proc. Natl. Acad. Sci. USA 95 (1998) 334-339.
131. M. Reincke, Mutations in adrenocortical tumors, Horm. Metab. Res. 30 (1998) 447-455.
132. A.F. Gazdar, H.K. Oie, C.H. Shackleton, T.R. Chen, T.J. Triche, C.E. Myers, G.P. Chrousos, M.F. Brennan, C.A. Stein, R.V. La Rocca, Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis, Cancer Res. 50 (1990) 5488-5496.
133. G.R. Stark, DNA amplification in drug resistant cells and in tumours, Cancer Surv. 5 (1986) 1-23.
134. J.R. Shapiro, W.R. Shapiro, The subpopulations and isolated cell types of freshly resected high grade human gliomas: their influence on the tumor's evolution in vivo and behavior and therapy in vitro, Cancer Metastasis Rev. 4 (1985) 107-124.
135. ATCC cell line product inserts. 2000. Manassas, VA, ATCC
136. V. Buonassissi, G. Sato, A.I. Cohen, Hormone-producing cultures of adrenal and pituitary tumor origin, Proc. Natl. Acad. Sci. USA 48 (1962) 1184-1190.
137. Y. Yasumura, V. Buonassisi, G. Sato, Clonal analysis of differentiated function in animal cell cultures Part 1. Possible correlated maintenance of differentiated function and the diploid karyotype, Cancer Res. 26 (1966) 529-535.
138. A. Biason-Lauber, E.J. Schoenle, Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF1) and adrenocortical insufficiency, Am. J. Hum. Genet. 67 (2000) 1563-1568.
139. B.K. Jordan, M. Mohammed, S.T. Ching, E. Delot, X.N. Chen, P. Dewing, A. Swain, P.N. Rao, B.R. Elejalde, E. Vilain, Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans, Am. J. Hum. Genet. 68 (2001) 1102-1109.
140. E. Treuter, T. Albrektsen, L. Johansson, J. Leers, J.A. Gustafsson, A regulatory role for RIP140 in nuclear receptor activation, Mol. Endocrinol. 12 (1998) 864-881.
141. R. White, G. Leonardsson, I. Rosewell, J.M. Ann, S. Milligan, M. Parker, The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility, Nat. Med. 6 (2000) 1368-1374.
142. W.B. Pratt, U. Gehring, D.O. Toft, Molecular chaperoning of steroid hormone receptors, EXS 77 (1996) 79-95.
143. S. Maheswaran, C. Englert, G. Zheng, S.B. Lee, J. Wong, D.P. Harkin, J. Bean, R. Ezzell, A.J. Garvin, R.T. McCluskey, J.A. DeCaprio, D.A. Haber, Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70, Genes Dev. 12 (1998) 1108-1120.
144. O.J. Marshall, V.R. Harley, Identification of an interaction between SOX9 and HSP70, FEBS Lett. 496 (2001) 75-80.
145. J.S. Colvin, R.P. Green, J. Schmahl, B. Capel, D.M. Ornitz, Male-to-female sex reversal in mice lacking fibroblast growth factor 9, Cell 104 (2001) 875-889.
146. C.K. Glass, D.W. Rose, M.G. Rosenfeld, Nuclear receptor coactivators, Curr. Opinion Cell Biol. 9 (1997) 222-232.
147. C. Leo, J.D. Chen, The SRC family of nuclear receptor coactivators, Gene 245 (2000) 1-11.
148. Y. Shi, M. Downes, W. Xie, H.Y. Kao, P. Ordentlich, C.C. Tsai, M. Hon, R.M. Evans, Sharp, an inducible cofactor that integrates nuclear receptor repression and activation, Genes Dev. 15 (2001) 1140-1151.
149. H. Shibata, Y. Ikeda, K. Morohashi, T. Mukai, I. Kurihara, T. Ando, T. Suzuki, S. Kobayashi, K. Hayashi, M. Hayashi, I. Saito, T. Saruta, Orphan receptors COUP-TF and DAX-1 as targets in disordered CYP17 expression in adrenocortical tumors, Endocr. Res. 26 (2000) 1039-1044.
150. H. Shibata, Y. Ikeda, T. Mukai, K. Morohashi, I. Kurihara, T. Ando, T. Suzuki, S. Kobayashi, M. Murai, I. Saito, T. Saruta, Expression profiles of coup-tf, dax-1, and sf-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis, Mol. Genet. Metab. 74 (2001) 206-216.
151. T. Omura, K. Morohashi, Gene regulation of steroidogenesis, J. Steroid Biochem. Mol. Biol. 53 (1995) 19-25.
152. Z.J. Wang, B. Jeffs, M. Ito, J.C. Achermann, R.N. Yu, D.B. Hales, J.L. Jameson, Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1, Proc. Natl. Acad. Sci. USA 98 (2001) 7988-7993.
153. S.K. Halder, H. Takemori, O. Hatano, Y. Nonaka, A. Wada, M. Okamoto, Cloning of a membrane-spanning protein with epidermal growth factor-like repeat motifs from adrenal glomerulosa cells, Endocrinology 139 (1998) 3316-3328.
154. T.W. Sandhoff, D.B. Hales, K.H. Hales, M.P. McLean, Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor 1, Endocrinology 139 (1998) 4820-4831.
155. D.J. Watts, S.H. Strogatz, Collective dynamics of 'small-world' networks, Nature 393 (1998) 440-442.
156. J.R. Banavar, A. Maritan, A. Rinaldo, Size and form in efficient transportation networks, Nature 399 (1999) 130-132.
157. A.L. Barabasi, R. Albert, Emergence of scaling in random networks, Science 286 (1999) 509-512.
158. Z. Burstein, A new concept of development and evolutionary adaptation, J. Soc. Biol. Struct. 14 (1991) 15-33.
159. J. van Helden, A. Naim, C. Lemer, R. Mancuso, M. Eldridge, S.J. Wodak, From molecular activities and processes to biological function, Brief Bioinform. 2 (2001) 81-93.
160. E. Zazopoulos, E. Lalli, D.M. Stocco, P. Sassone-Corsi, DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis, Nature 390 (1997) 311-315.
161. K. Morohashi, S. Honda, Y. Inomata, H. Handa, T. Omura, A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s, J. Biol. Chem. 267 (1992) 17913-17919.
162. J.W. Foster, M.A. Dominguez-Steglich, S. Guioli, G. Kwok, P.A. Weller, M. Stevanovic, J. Weissenbach, S. Mansour, I.D. Young, P.N. Goodfellow, J.D. Brook, A.J. Schafer, Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene, Nature 372 (1994) 525-530.
163. K. Kawabe, T. Shikayama, H. Tsuboi, S. Oka, K. Oba, T. Yanase, H. Nawata, K. Morohashi, Dax-1 as one of the target genes of Ad4BP/SF-l, Mol. Endocrinol. 13 (1999), 1267-1284.
164. E. Lalli, M.H. Melner, D.M. Stocco, P. Sassone-Corsi, DAX-1 blocks steroid production at multiple levels, Endocrinology 139 (1998) 4237-4243.
165. X. Yuan, M.L. Lu, T. Li, S.P. Balk, SRY interacts with and negatively regulates androgen receptor transcriptional activity, J. Biol. Chem. 276 (2001) 46647-46654.
166. B.P. De Santa, N. Bonneaud, B. Boizet, M. Desclozeaux, B. Moniot, P. Sudbeck, G. Scherer, F. Poulat, P. Berta, Direct interaction of SRY-related protein SOX9 and steroidogenic factor1 regulates transcription of the human anti-Mullerian hormone gene, Mol. Cell. Biol. 18 (1998) 6653-6665.
167. N.A. Hanley, W.E. Rainey, D.I. Wilson, S.G. Ball, K.L. Parker, Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation, Mol. Endocrinol. 15 (2001) 57-68.
168. K. Morohashi, U.M. Zanger, S. Honda, M. Hara, M.R. Waterman, T. Omura, Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP, Mol. Endocrinol. 7 (1993) 1196-1204.
169. Y. Toyooka, S.S. Tanaka, O. Hirota, S. Tanaka, N. Takagi, K. Yamanouchi, H. Tojo, C. Tachi, Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY, Int. J. Dev. Biol. 42 (1998) 1143-1151.
170. D. Tautz, A genetic uncertainty problem, Trends Genet. 16 (2000) 475-477.
171. J. Vockley, P. Rinaldo, M.J. Bennett, D. Matern, G.D. Vladutiu, Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways, Mol. Genet. Metab. 71 (2000) 10-18.
172. W.P. Blackstock, M.P. Weir, Proteomics: quantitative and physical mapping of cellular proteins, Trends Biotechnol. 17 (1999) 121-127.
173. B.L. Drees, B. Sundin, E. Brazeau, J.P. Caviston, G.C. Chen, W. Guo, K.G. Kozminski, M.W. Lau, J.J. Moskow, A. Tong, L.R. Schenkman, A. McKenzie III, P. Brennwald, M. Longtine, E. Bi, C. Chan, P. Novick, C. Boone, J.R. Pringle, T.N. Davis, S. Fields, D.G. Drubin, A protein interaction map for cell polarity development, J. Cell Biol. 154 (2001) 549-571.